Explore
Validate
LearnAF2379
antibody from R&D Systems
Targeting: CD93
C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- AF2379 - Provider product page
- Provider
- R&D Systems
- Product name
- Human C1qR1/CD93 Antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified. Detects human C1q R1/CD93 in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant mouse C1q R1 is observed.
- Reactivity
- Human
- Host
- Goat
- Conjugate
- Unconjugated
- Antigen sequence
Q9NPY3- Isotype
- IgG
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Soluble CD93 is an apoptotic cell opsonin recognized by αx β2.
Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
Soluble CD93 levels in patients with acute myocardial infarction and its implication on clinical outcome.
Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.
Blackburn JWD, Lau DHC, Liu EY, Ellins J, Vrieze AM, Pawlak EN, Dikeakos JD, Heit B
European journal of immunology 2019 Apr;49(4):600-610
European journal of immunology 2019 Apr;49(4):600-610
Elevated expression of CD93 promotes angiogenesis and tumor growth in nasopharyngeal carcinoma.
Bao L, Tang M, Zhang Q, You B, Shan Y, Shi S, Li L, Hu S, You Y
Biochemical and biophysical research communications 2016 Aug 5;476(4):467-474
Biochemical and biophysical research communications 2016 Aug 5;476(4):467-474
Soluble CD93 levels in patients with acute myocardial infarction and its implication on clinical outcome.
Youn JC, Yu HT, Jeon JW, Lee HS, Jang Y, Park YW, Park YB, Shin EC, Ha JW
PloS one 2014;9(5):e96538
PloS one 2014;9(5):e96538
Plasma CD93 concentration is a potential novel biomarker for coronary artery disease.
Mälarstig A, Silveira A, Wågsäter D, Öhrvik J, Bäcklund A, Samnegård A, Khademi M, Hellenius ML, Leander K, Olsson T, Uhlén M, de Faire U, Eriksson P, Hamsten A
Journal of internal medicine 2011 Sep;270(3):229-36
Journal of internal medicine 2011 Sep;270(3):229-36
No comments: Submit comment
No validations: Submit validation data